register

News & Trends - Pharmaceuticals

Legislative changes for improved access to important medicines

Health Industry Hub | June 29, 2020 |

Pharma News: Queenslanders will now have improved access to oral contraceptives and medicinal cannabis following legislative amendments made by the Queensland Government.

While women have been able to access a supply of PBS subsidised oral contraceptive without a valid repeat prescription since 2012, this amendment will provide access to non-PBS subsidised brands of oral contraceptives.

Pharmaceutical Society of Australia (PSA) Queensland Branch President Shane MacDonald welcomed the amendment that will help address the inequity of access to oral contraceptives.

“Enabling the supply of all brands of oral contraceptives to women, under similar circumstances to those stipulated in the PBS Continued Dispensing Determination is a common sense approach by the Queensland Government, he said.

“It is important that women in Queensland are able to access the brand of oral contraceptive they require when there is an immediate need for the supply to allow for continued treatment.”

The Queensland Government also announced it has made an amendment allowing all Queensland medical practitioners to prescribe schedule 8 and schedule 4 medicinal cannabis without the requirement to have a Queensland Health approval.

Previously, only specialist medical practitioners were able to prescribe these medicines without first applying for Queensland Health approval.

Mr MacDonald said this amendment will remove duplication in the approval process and simplify prescribing of medicinal cannabis.

“Decreasing the administrative burden and improving access to medicinal cannabis is an important step to ensure patients continue to access cannabis products legally,” he said.

“Any process that removes red tape and allows pharmacists and prescribers to focus on clinical care and medication safety, ultimately leads to better outcomes for patients and more efficient use of resource.

Approval from Queensland Health is still required when prescribing a schedule 8 medicinal cannabis product for a drug dependent person and the usual approval process for prescribing controlled drugs applies.


News & Trends - Pharmaceuticals

New combination therapy improves survival rates for Aussies with advanced prostate cancer

New combination therapy improves survival rates for Aussies with advanced prostate cancer

Health Industry Hub | February 14, 2025 |

A world-first treatment approach has demonstrated significant advancements in the management of metastatic castration-resistant prostate cancer (mCRPC) compared to conventional […]

More


News & Trends - Pharmaceuticals

'Don't just learn what illness is, learn what it feels like,' Dr Ben Bravery

‘Don’t just learn what illness is, learn what it feels like,’ Dr Ben Bravery

Health Industry Hub | February 14, 2025 |

With the iconic Sydney Harbour as a backdrop, the Merck Healthcare team came together for a dynamic and engaging kick-off […]

More


News & Trends - MedTech & Diagnostics

GE HealthCare, Lumus Imaging and GenesisCare unite to bring advanced technology to patients

GE HealthCare, Lumus Imaging and GenesisCare unite to bring advanced technology to patients

Health Industry Hub | February 14, 2025 |

GE HealthCare and Lumus Imaging have joined forces to enhance medical care in Sydney’s Campbelltown region, unveiling a state-of-the-art imaging […]

More


News & Trends - MedTech & Diagnostics

World-First mobile CT for regional healthcare

World-First mobile CT for regional healthcare

Health Industry Hub | February 14, 2025 |

An Australian X-ray technology company developing a world-first full-body mobile CT following the award of an up to US$16.4m (A$25m) […]

More


This content is copyright protected. Please subscribe to gain access.